|
ABOS Acumen Pharmaceuticals Inc 1576885 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-32,718,000.00 |
| Balance Sheet |
|
Current Assets
|
$115,513,000.00 |
|
Assets
|
$116,007,000.00 |
|
Current Liabilities
|
$46,848,000.00 |
|
Liabilities
|
$58,744,000.00 |
|
Equity
|
$57,263,000.00 |
|
Shares Out
|
72314714.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-42,203,000.00 |
|
Investing Cash Flow
|
$12,193,000.00 |
| Market Analysis |
Market Cap
|
$230,683,937.66 |
|
Price
|
$3.19 |
|
BVPS
|
0.79 |
|
PB
|
4.04 |
|
EPS
|
-0.45 |
|
FCF
|
$-42,203,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:48 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:39 |
|
| Apr |
May |
Jun |
| 2026-03-26 |
-2.00 |
|
|
2026-05-12 |
-0.33 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.68 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.44 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ABOS documents filed with the SEC.
ABOS Filings
Clear
